(Q46616767)

English

Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients

scientific article published on 23 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

object named as

Elena Seminari

1

0 references

Antonella Castagna

object named as

Antonella Castagna

8

0 references

Adriano Lazzarin

object named as

Adriano Lazzarin

10

0 references

author name string

Monica Guffanti

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Paola Villani

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Nicola Gianotti

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Maria Cusato

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Giuliana Fusetti

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Andrea Galli

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Mario Regazzi

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

publication date

23 July 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

61

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

545-549

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

https://scigraph.springernature.com/pub.10.1007/s00228-005-0966-x

0 references

The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0966-X

21 January 2018

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0966-X

21 January 2018

Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unfavourable interaction of amprenavir and lopinavir in combination with ritonavir?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High variability of plasma drug concentrations in dual protease inhibitor regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16041598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-005-0966-X

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16041598

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46616767&oldid=2143979238"